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Available online 20 April 2012The cholinergic system plays a major role in learning and cognition and cholinergic neurons
appear to be particularly vulnerable to ethanol (EtOH) exposure. There are conflicting results if
EtOH directly damages cholinergic neurons. Thus, the aims of the present study were (1) to
investigate the effect of different EtOH concentrations on cholinergic neurons in organotypic
brain slices of the nucleus basalis of Meynert (nbM) and (2) to study if the most potent
cholinotrophic substance nerve growth factor (NGF) or inhibitors of mitogen activated kinase
(MAPK) p38- and nitric-oxide synthase (NOS)-pathways may counteract any EtOH effect. Two-
weekold organotypic rat brain slices of thenbMwereexposed to 1–100mMEtOH for 7 dayswith
or without drugs and the number of choline-acetyltransferase (ChAT)-positive neurons was
counted. Our data show that EtOH significantly reduced the number of ChAT-positive neurons
with themost potent effect at a concentration of 50 mMEtOH (54±5 neurons per slice, p<0.001),
compared to control slices (120±13 neurons per slice). Inhibition ofMAPKp38 (SB 203580, 10 μM)
andNOS (L-thiocitrulline, 10 μM) counteracted the EtOH-induced decline of cholinergic neurons
and NGF protected cholinergic neurons against the EtOH-induced effect. Withdrawal of EtOH
resulted in a reversal of cholinergic neurons to nearly controls. In conclusion, EtOH caused a
transient decline of cholinergic neurons, possibly involving MAPK p38- and NOS-pathways
suggesting that EtOHdoesnot induce direct cell death, but causes a transient downregulation of
the cholinergic key enzyme, possibly reflecting a form of EtOH-associated plasticity.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.Keywords:
Ethanol
Cholinergic neurons
Choline-acetyltransferase
downregulation
Neuroprotection1. Introduction
The cholinergic system plays an important role in cognition
and memory and is severely impaired in neurodegenerative
diseases such as Alzheimer's disease (AD), vascular dementia
(vaD) or alcohol-related dementia. A lack of the neurotrans-
mitter acetylcholine directly correlates with cognitive decline.
It is well known that chronic ethanol (EtOH) exposure results
in decreased levels of acetylcholine, choline-acetyltransferase
(ChAT) and acetylcholine-esterase in the basal forebrain
(Arendt, 1994; Arendt et al., 1988, 1995; Costa and Guizzetti,chiatry and Psychotherap
.ac.at (C. Humpel).
 CC BY-NC-ND license.1999; Floyd et al., 1997; Jamal et al., 2009; Kentroti and
Vernadakis, 1996; McKinney, 2005; Olton, 1983). There is
strong controversy if alcohol consumption has positive or
negative influence on development of dementia. Heavy
drinking is a risk factor for most stroke subtypes favoring
vascular damage in the brain which may be of importance in
the development of vaD and possibly AD (Humpel, 2011;
Sundell et al., 2008). Moderate alcohol consumption has been
reported to lower the risk for AD, as well as other types of
dementia (Huang et al., 2002; Ruitenberg et al., 2002). In fact
several studies indicate that moderate chronic EtOH does noty, Anichstr. 35, A-6020 Innsbruck, Austria. Fax: +43 512 504 23713.
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(Anstey et al., 2009; Graves et al., 1990; Neafsey and Collins,
2011; Rosen et al., 1993; Tanaka et al., 2002). Alcohol-related
dementia is completely different to AD etiology and patho-
genesis, but has some similar clinical symptoms, such as e.g.
cognitive decline (Aho et al., 2009). Some of the EtOH-induced
toxic effects, especially on cholinergic neurons, are similar to
those observed in AD and vaD possibly pointing to a common
pathogenesis.
EtOH easily passes the blood–brain barrier (BBB) and interacts
with various signal transduction cascades (Aroor and Shukla,
2004; Ku et al., 2007), ion channels (Allgaier, 2002), second
messengers (Deng and Deitrich, 2007), neurotransmitters
(Foddai et al., 2004; Jamal et al., 2007) and their receptors
(Diamond and Messing, 1994). EtOH causes brain damage
(Harper and Matsumoto, 2005), induces inflammatory processes
(Blanco and Guerri, 2007; Crews and Nixon, 2009; Vallés et al.,
2004), increases NF kappaB‐DNA binding (Crews et al., 2006; Zou
and Crews, 2006), enhances cytokine-mediated inducible nitric
oxide synthase (iNOS) production in astrocytoma cells (Davis et
al., 2002) as well as in adolescent brain slice cultures (Zou and
Crews, 2010). EtOH alters amyloid-precursor protein (APP) and
APP processing enzymes (Kim et al., 2011; Lahiri et al., 2002),
enhances the accumulation of hyperphosphorylated tau proteinFig. 1 – Immunohistochemical staining of cholinergic neurons in
Slices were cultured for 2 weeks with nerve growth factor (NGF)
without (A, B) or with 50 mM ethanol (EtOH; C, D) for 7 days. Slic
choline-acetyltransferase (ChAT) was performed. Several ChAT+
markedly reduced the number of ChAT+ neurons in the slices (C(Sun et al., 2005), andmay lead to neuritic plaques in rats (Paula-
Barbosa and Tavares, 1984), all pathological hallmarks seen in
AD. In order to investigate a direct effect of EtOH on cholinergic
neurons we aim to explore the consequence of direct EtOH-
exposure on ChAT-positive neurons in organotypic brain slices
of the nucleus basalis of Meynert (nbM). Furthermore, we will
study if NGF or inhibition of NO- and mitogen activated kinase
(MAPK) p38-pathways may mediate any EtOH-induced effects
on cholinergic nbMneurons. In fact, wewill show that EtOHdoes
not induce cell death of cholinergic neurons, but rather causes a
transient decline of the enzyme ChAT, possibly reflecting a form
of EtOH-associated plasticity.2. Results
2.1. Effects of EtOH on cholinergic neurons
Cholinergic neurons in nbM organotypic brain slices were
visualized by ChAT-like immunohistochemistry (Fig. 1). In
2-week old control slices approximately 120 neurons were
detectable (Figs. 1A, B) and this number did not change when
sliceswere incubated for further 2 weekswithout NGF.When 2-
week old slices were incubated with different concentrations oforganotypic rat brain slices of the basal nucleus of Meynert.
and for 3 days without NGF. Thereafter slices were cultured
es were then fixed and immunohistochemistry for
neurons are shown in control slices (A, B) whereas EtOH
, D). Scale bar in A=280 μm (A, C) and=45 μm (B, D).
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seen at concentrations >10mM EtOH (Figs. 1C, D). The EtOH
effect wasmost pronounced at 50 mMbut the number of ChAT+
neurons did not further decrease at higher concentrations
(Fig. 2A). No effect was visible at 1 mM EtOH (Fig. 1A). When
2 week old slices where incubated with 50mM EtOH for further
14 days, thenumber of ChAT+neuronsmarkedly declined to <20Fig. 2 – Effects of ethanol (EtOH) and inhibitors on cholinergic
neurons. Brain slices were cultured for 2 weeks with nerve
growth factor (NGF), then 3 days without NGF and incubated
further for 7 days without or with 1–100 mM EtOH with or
without 10 ng/ml NGF (A). Slices were treated without (Co) or
with 50 mM EtOH (−) and with or without 10 μM MAPK p38
inhibitor (INH) or with or without 10 μM L-thiocitrulline
(L-Thio) (B). Slices were fixed and stained for
choline-acetyltransferase (ChAT). Values are given as mean
±SEM number of ChAT+ neurons per slice (numbers in
parenthesis give the number of analyzed slices). Statistical
analysis was performed by one way ANOVA followed by
Fisher LSD post hoc test; (*p<0.05;**p<0.01, ***p<0.001; ns,
not significant; § p<0.05 versus EtOH alone).neurons per slice (Fig. 2). When EtOH was withdrawn from the
culture medium, the number of cholinergic neurons returned to
control levels (Fig. 3).
2.2. Effects of NGF on EtOH-induced decline of cholinergic
neurons
When 2-week old slices were incubated with EtOH and NGF,
NGF counteracted the EtOH-induced effect at 100 mM (Fig. 2A),
but not at 50 mM EtOH (Fig. 2A). When 2-week old slices were
incubated with 50 mM EtOH for 1 week and then for further
1 week with or without NGF, the number of ChAT+ neurons
returned to nearly control levels (Fig. 3). However, when
2-week old slices were incubated with 50 mM EtOH for further
7 to 14 days with NGF and EtOH, the number of cholinergic
neurons did not change (Fig. 3).
2.3. Effects of inhibitors of MAPK p38 and NOS on
cholinergic neurons
In order to test underlying pathway mechanisms of EtOH-
induced effects, slices were treated with NOS and MAPK p38Fig. 3 – Effects of ethanol (EtOH) withdrawal on cholinergic
nbM neurons. Brain slices were cultured for 2 weeks with
nerve growth factor (NGF) and then exposed to medium
without NGF or with 50 mM EtOH for 7 days. Some slices were
further treated for 7 days with or without NGF and with or
without 50 mMEtOH orwithNGF and50 mMEtOH. Sliceswere
fixed and immunohistochemically stained for the enzyme
choline-acetyltransferase (ChAT). The number of cholinergic
neurons was not different when incubated for 2 weeks with
NGF or for 2 weeks without NGF. EtOH treatment resulted in a
significant decrease in ChAT+ neurons after 7 days and more
pronounced after 14 days. When EtOH was withdrawn, the
number of cholinergic neurons nearly recovered to control
levels, but NGF did not counteract the EtOH effect, when given
togetherwith EtOH. Values are given asmean±SEMnumber of
ChAT-positive neurons per slice. Values in parenthesis give
the number of analyzed slices. Statistical analysis was
performedby onewayANOVA followed by Fisher LSDposthoc
test (***p<0.001).
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SB203580 (MAPK p38 inhibitor) for 7 days counteracted the
EtOH-induced decline (Fig. 2B). Incubation of slices with
SB203580 alone did not have any effects on ChAT+ neurons
(Fig. 2B). Treatment of slices with 50 mM EtOH together with
L-thiocitrulline (NOS inhibitor) for 7 days counteracted the
EtOH-induced decline (Fig. 2B). Incubation of slices with
L-thiocitrulline alone did not show any effects (Fig. 2B).
2.4. Effects of EtOH on inflammatory markers
Inflammatory markers were measured in slices by multiplex
ELISAs and the levels of control slices were 45±18 pg/mg
(macrophage-inflammatory protein-2, MIP-2), 18±4 pg/mg
(tumor necrosis factor-alpha, TNF-α), 171±34 pg/mg (macro-
phage-chemotactic protein-1, MCP-1), 42±15 pg/mg (interleukin-
1beta, IL-1β) and 1421±593 pg/mg (matrix-metalloproteinase-2,
MMP-2) (all, n=6). EtOH (50mM, 7 days) did not affect the levels of
all measured markers.3. Discussion
The present study shows that EtOH induces a decline of
cholinergic neurons, most likely by involving MAPK p38 and
NO pathways. The decrease of cholinergic neurons in nbM
slices may be caused by a transient downregulation of the
enzyme ChAT pointing rather to a form of adaptive plasticity in
response to the EtOH treatment, than to neurodegeneration.
The organotypic brain slice model is well-established in
our working group and serves as a validated tool to study
toxic, degenerative and developmental changes as well as
synaptic recovery, survival and cell death of neurons
(Gähwiler et al., 1997; Humpel and Weis, 2002; Moser et al.,
2003, 2006; Stoppini et al., 1991; Weis et al., 2001; Zassler et al.,
2003). In this model cholinergic neurons are axotomized,
however, the normal cytoarchitecture is retained similar to
the in vivo situation and functional connections including
transport and diffusion probabilities are maintained. The
brain tissue is derived from postnatal day 10 brains and
therefore it is not completely comparable to adult brains,
which is a limitation of the present study. In further studies it
would be of particular interest to investigate the effects of
EtOH in adult nbM slices and thus to compare with the
neuropathological changes in adult brains. In fact, culturing of
adult brain slices has been reported (Bickler et al., 2010;
Hassen et al., 2004; Xiang et al., 2000), although this technique
is not trivial and such slices are not easy to culture for long
time.
Adolescent brains distinctively response to EtOH exposure
compared to adult brains (Smith, 2003) and the context of
ongoing plasticity in the adolescence faces the continuous
production of new neurons during adult neurogenesis (Nixon
et al., 2010). Indeed, adolescents are more prone to the
neurotoxic effects of EtOH than adults (Crews et al., 2007). In
the present model brain slices are normally cultured for
2 weeks before staining in experiments correlating to adoles-
cent age. In fact the basal forebrain cholinergic neurogenesis is
already completed before birth (E17) (Semba and Fibiger, 1988).
In the present study detection of cholinergic neurons wasperformed using the immunohistochemical marker for the
enzyme ChAT, which is expressed in cell bodies and nerve
fibers of cholinergic neurons. In our experiments control slices
displayed around 120 ChAT-positive neurons, which is in line
with previous work (Weis et al., 2001). ChAT serves as a marker
for the functional activity of cholinergic neurons (Oda, 1999)
and a decreased number directly correlates with cognitive
impairment (Counts and Mufson, 2005). Indeed, a dysfunction
of the cholinergic system and the loss of cholinergic neurons is
in concert with low levels of acetylcholine in the cortex and
resulted in cognitive impairment (Mesulam, 2010). Interesting-
ly, an impairment of the cholinergic system (Floyd et al., 1997)
and cognitive decline has also been reported after long-term
EtOH treatment in vivo (Arendt et al., 1988; Ehrlich et al., 2012).
Accordingly, the activity of cholinergic neurons after EtOH
exposure possibly represents a depression of the enzyme ChAT
and not cell death. In fact in the present in vitro study we show
that cholinergic neurons in adolescent nbM slices reverse to
nearly control levels after withdrawal of EtOH suggesting
reversible effects of EtOH. This is also in agreement with
Arendt et al. (1989) showing that in rats treated for 8 weeks
with EtOH a full recovery of declined ChAT activity in the basal
forebrain is seen after 4 weeks of EtOH withdrawal. The effects
of EtOH on the cholinergic system may reflect a form of
adaptive plasticity, rather than neurodegeneration after EtOH
exposure in our brain slice model.
In the present studyweused EtOH concentrations from1mM
(5mg/dl) up to 100mM (500mg/dl). EtOH concentrations be-
tween 50mM (250mg/dl) to 70 mM (350mg/dl) are of particular
interest, because these levels has been reported in alcohol
dependent adults as well as adolescent humans (Deas et al.,
2000; Jones andHolmgren, 2009) andwere also used in several in
vitro studies (Cheema et al., 2000; Mooney and Miller, 2003; Zou
and Crews, 2010). The sensitivity of the cholinergic system to
EtOH has been reported in previous in vivo studies (Arendt et al.,
1988, 1995; Floyd et al., 1997). In rats prolonged intake of EtOH
resulted in a neurotoxic effect on the basal forebrain cholinergic
projection system (Floyd et al., 1997) and leads to a partial
cholinergic denervation of the cortex, hippocampus and amyg-
dala (Arendt et al., 1988). Beside the cholinergic system, EtOH
affects also other brain areas and EtOH-induced apoptotic cell
death in the developing cortex has been observed in organotypic
cultures (Mooney andMiller, 2003). In the present study themost
prominent decrease of cholinergic neurons of approximately
60% of total neurons was found after treatment with 50mM
(250mg/dl) EtOH, but not at higher concentrations. This surpris-
ing finding is consistent with data reported by Cheema et al.
(2000), who showed that cell death was enhanced in cultures
after treatment with 64mM (320mg/dl) EtOH but not at 190mM
(950mg/dl). Others reported that 80 mM (400mg/dl) EtOH
increased cell death in the cortical plate in cultures of rat
cerebral cortex, whereas the highest amounts of 160mM
(800mg/dl) hadno effect (MooneyandMiller, 2003). Interestingly,
also in human astroglia cells EtOH displayed a biphasic effect:
50 mM EtOH stimulated while 200mM EtOH inhibited a
cytokine-induced iNOS activity (Davis et al., 2002). In our present
study we suggest that a saturating effect of <50mM EtOH may
stimulate a specific single pathway, while at EtOH levels>50mM
a second, independent and protective pathway may become
activated.
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potent trophic substance to support survival of cholinergic
neurons (Humpel andWeis, 2002; Levi-Montalcini et al., 1996).
In vivo studies showed an increase of NGF mRNA levels in a
number of brain areas, including the basal forebrain and their
cortical target areas, after chronic EtOH treatment in rats
(Arendt et al., 1995). In addition, it has been reported that NGF
is able to counteract EtOH-induced deficits in the cholinergic
system (Aloe and Tirassa, 1992; Lukoyanov et al., 2003; Paula-
Barbosa et al., 2001), as well as in cultured cortical (Mooney
and Miller, 2007), hippocampal (Webb et al., 1997) and
cerebellar neurons (Luo et al., 1997). In our slice model
cholinergic neurons were cultivated for two weeks with NGF
from beginning resulting in around 120 detectable ChAT+
neurons. This number did not change, when slices were
cultured for further 2 weeks without NGF. We have well
established that cholinergic neurons survive at least for
2 weeks without NGF, but not longer (Weis et al., 2001). In
the present study only the EtOH-induced effect was counter-
acted by NGF at 100 mM, but not at 50 mM effect. This again
may point to a second independent (possibly neuroprotective)
intracellular pathway, which is only activated at higher EtOH
concentrations.
In order to investigate intracellular pathways of EtOH-
induced effects on cholinergic neurons, we investigated two
well established pathways. (1) The MAPK pathway may play
an important role in EtOH-induced neurotoxicity. EtOH in-
duces oxidative stress, which further has been shown to
activate all three MAPK cascades, p42/44, JNK/SAPK and the
MAPK p38 (Owuor and Kong, 2002). The role of MAPK p38 is
divergent, because MAPK p38 pathways may be involved in
anti-apoptotic processes (Roberts et al., 2000), but may also
increase the vulnerability to cell death (Aroor and Shukla,
2004). It has been shown that MAPK p38 cascades may be
responsible for EtOH-induced cell cycle arrest and inhibition
(Koteish et al., 2002). Interestingly, in the present study the
treatment with a MAPK p38 inhibitor counteracted the EtOH-
induced decline of cholinergic neurons. (2) EtOH is able to
activate free radical generating enzymes, such as NAPDH
oxidase and iNOS, may induce reactive oxygen species
(Alikunju et al., 2011) and modulates NO activity by inducing
oxidative stress. EtOH directly alters NOS expression and
activity in the brain (Davis and Syapin, 2005; Syapin, 1998)
causing blood pressure elevation and regional blood flow
reduction (Toda and Ayajiki, 2010). Inhibition of NO has been
suggested as a possible treatment against EtOH-induced
excitotoxicity and addiction (Lancaster, 1995). However,
there is strong indication that NO is not involved in EtOH-
associated brain damage (Vassiljev et al., 1998; Zou et al.,
1996). In the present study the EtOH-induced decline of
cholinergic neurons in the nbM was counteracted by inhibi-
tion of NOS activity suggesting that the NO cascade is
involved in EtOH-mediated in vitro effects. However, in vivo
NO may induce some additional protective pathways. Unfor-
tunately, a shortcoming in our slice model is the lack of
functional vascularization to study aspects of NO-mediated
vasodilatation. Further investigations are necessary to ex-
plore if NO has a direct effect against the decline of neurons in
the organotypic slice model and if this is comparable to the in
vivo situation.In our slices treatment with EtOH did not result in
enhanced cytokine production. It seems likely that this
treatment was not strong enough to induce an inflammatory
cascade in the nbM. Indeed, EtOH-induced inflammation in
humans has been shown after chronic alcoholism and is not a
short time effect. In addition, cytokines found in the brains of
individuals after heavy EtOH consume are originally produced
by the liver cells (Crews and Nixon, 2009). Thus, any lack of
direct EtOH on inflammation is in line with such a peripheral
inflammatory process. In hippocampal–entorhinal brain slice
cultures EtOH induced inflammatory gene expression (Zou
and Crews, 2010), suggesting that this region may be more
sensitive to EtOH-induced cytokine upregulation than the
nbM. Further studies are necessary to investigate if the lack of
inflammation in our slice model is area-related or a method-
ological limitation.
Taken together, our data show that EtOH-induced a decline
of cholinergic neurons in vitro, which was partly counteracted
by NGF. Inhibition of MAPK p38 and NOS ameliorated the
EtOH effect suggesting a role in the underlying mechanism of
EtOH-mediated effects in vitro. In conclusion, the data may
suggest that direct EtOH exposure to cholinergic nbM neurons
may transiently suppress the enzyme ChAT and may not
induce cell death of cholinergic neurons, but rather may
reflect a form of neuronal plasticity in response to EtOH.4. Experimental procedures
4.1. Organotypic brain slices
Cholinergic neurons in organotypic brain slices were cultured,
as described in detail previously (Humpel and Weis, 2002;
Weis et al., 2001). Briefly, the basal nucleus of Meynert (nbM)
of postnatal day 10 (P10) rats was dissected under aseptic
conditions. Further, 400 μm slices were cut with a tissue
chopper (McIlwain, USA) and placed on 30 mm Millicell-CM
0.4 μm pore membrane culture plate inserts (6–8 slices per
membrane). It needs to be pointed out that a single experi-
ment included approximately 8–12 pups. In one dissection
experiment 4 pups were dissected and all brain slices were
randomly distributed on all 6-wells. An experiment was
normally repeated 3 times on different groups, so that a
single treatment contained at least slices from 9 different rat
pups. Slices were cultured in 6-well plates at 37 °C and 5% CO2
with 1.2 ml/well of slice medium (50% MEM/HEPES (Gibco),
25% heat inactivated horse serum (Gibco/Lifetech, Austria),
25% Hanks' solution (Gibco), 2 mM NaHCO3 (Merck, Austria),
6.5 mg/ml glucose (Merck), 2 mM glutamine (Merck), pH 7.2)
including 10 ng/ml nerve growth factor (NGF) for 2 weeks. It is
well established that the 400 μm brain slices become thinner
during the 2 weeks of incubation resulting in a thickness of
approx. 100 μm, which is a sign of healthy cultures. Slices,
which did not flatten were immediately removed from the
experiments. For all experiments the 2-week old slices were
cultured for 3 days without NGF and then transferred to
different media with 1 to 100 mM EtOH. In some experiments
10 μM L-thiocitrulline (nitric oxide synthase inhibitor) or
10 μM SB203580 (MAPK p38 inhibitor) were added for further
7 or 14 days, respectively.
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Immunohistochemistry using the avidin–biotin technique
was performed to detect cholinergic neurons, as described
previously (Zassler and Humpel, 2006). All incubations were
processed free-floating at 4 °C for 2 days including 0.1% Triton,
allowing good penetration of the antibody into the slices from
both sides. Fixed slices were rinsed 30 min with 0.1% Triton/
PBS (T-PBS) at room temperature and pre-treated for 20 min
with 20%methanol/1%H2O2/PBS. Then the sliceswerewashed
three times for 10 min with PBS, blocked with 20% horse
serum/0.2% BSA/T-PBS and then incubated with the primary
antibody against goat anti-choline‐acetyltransferase (1:750,
Millipore, USA) in 0.2% BSA/T-PBS for 2 days at 4 °C. Sliceswere
washed and incubated with secondary biotinylated anti-goat
antibody (1:200, Vector Laboratories), for 1 h at room temper-
ature. After rinsing three times in PBS, sliceswere incubated in
avidin–biotin complex solution (ABC; Elite Standard PK 6100,
Vector Laboratories) for 1 h, thenwashed three times in 50 mM
Tris-buffered saline (TBS) and the signal was detected using
0.5 mg/ml 3,3′diaminobenzidine (DAB) in TBS with 0.003%
H2O2 as substrate. Slices were then rinsed in PBS andmounted
on glass slides.
4.3. ELISA (MIP-2, TNF-α, MCP-1, IL-1β and MMP-2)
Slices were extracted in 100 μl ice-cold sodium-phosphate
buffer (PBS) with protease-inhibitor cocktail (Sigma, Germany)
using an ultrasonic device (Branson sonifier 250) and centri-
fuged at 16 000×g for 10min at 4 °C. Inflammatorymarkers and
MMP-2 were analyzed in slice extracts using a rat Multiplex
ELISA (SearchLight®; Aushon Biosystems), as described previ-
ously (Marksteiner et al., 2011; Pirchl et al., 2010).
4.4. Quantitative analysis and statistics
All neuronal counts were based on individual sections and
show total number of neurons per slices. The number of
microscopically detectable immunoreactive ChAT+ neurons
was counted in the whole slice visualized under a 40×
objective by an investigator blinded to the treatment code.
Quantitative data are presented as mean±SEM. Multistatis-
tical analysis was obtained by one way ANOVA, followed by a
subsequent Fisher PLSD posthoc test by comparing controls
against the respective treatments, where p<0.05 represents
statistical significance.Acknowledgments
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